iCAD, Inc. (NASDAQ: ICAD) today announced approval by the U.S. Food and Drug Administration (FDA) for use of the Company's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE